Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cohort Studies of Impact of Pretreatment Emotional on Survival and the Predictive Role of Peripheral Blood Metabolic and Inflammatory Markers in Immunotherapy Response Among Treatment-Naïve, Advanced and Inoperable Gastroesophageal and Non-Small-Cell Lung Cancer Patients

NCT06629714 is registered in ClinicalTrials.gov with Anhui Medical University as lead sponsor.

NCT NCT06629714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06629714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cohort Studies of Impact of Pretreatment Emotional on Survival and the Predictive Role of Peripheral Blood Metabolic and Inflammatory Markers in Immunotherapy Response Among Treatment-Naïve, Advanced and Inoperable Gastroesophageal and Non-Small-Cell Lung Cancer Patients
Lead sponsor
Anhui Medical University
Phase
Observational
Overall status
Completed
Start date
October 16, 2020
Completion date
April 20, 2025
Enrollment
196 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biomarkers / blood, cancer, treatment-related, emotional distress, gastroesophageal cancer (gc), immune checkpoint inhibitors, inflammation, non small cell lung cancer, progression-free survival, pfs